Skip to content

Effects of exercise training on depressive symptom and cognitive function in hemodialysis patients

Effects of exercise training on depressive symptom and cognitive function in hemodialysis patients - Exercise training in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000029372
Enrollment
30
Registered
2017-10-02
Start date
2017-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patients

Interventions

intervention group: exercise training during dialysis control group: strtching during dialysis intervention group: 6 months control group: 6 months

Sponsors

The Department of Psychiatry, Kawagoe Clinic, Saitama Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Hemodialysis outpatients 2) Patients from whom written informed consent was obtained

Exclusion criteria

Exclusion criteria: 1)Patients who are contraindicated for exercise training. Concrete criteria are as follows: -Patients who were diagnosed with heart failure and whose subjective symptoms of heart failure worsened within the past week -Patients with unstable angina pectoris Myocardial ischemic patients with low threshold -Patients who developed acute myocardial infarction within the past month -Patients with severe left ventricular efflux stenosis (obstructive hypertrophic cardiomyopathy, etc.) -Patients with untreated exercise-induced severe arrhythmia (ventricular fibrillation, sustained ventricular tachycardia) -Patients with poorly controlled arrhythmia -Patients with active myocarditis / pericarditis -Patients with acute aortic dissection -Patients with other disorders in which exercise therapy is contraindicated (moderate or higher degrees of aortic aneurysm, severe hypertension, thrombophlebitis, embolism within the past 2 weeks, severe multiple organ disorder, etc.)

Design outcomes

Primary

MeasureTime frame
depressive symptom: PHQ-9 cognitive function: MoCA-J pre-intervention, 3 months, 6 months, 12 months

Secondary

MeasureTime frame
sleep quality: Athens insomnia scale behavioral and psychological symptoms of dementia: NPI-Q(The Neuropsychiatric Inventory Questionnaire) ADL: Barthel Index Physical function: Knee Extension Muscle Strength, Weight Bearing Index, Grip Strength pre-intervention, 3 months, 6 months, 12 months

Countries

Japan

Contacts

Public ContactNaoshi Horikawa

Kawagoe Clinic, Saitama Medical University The Department of Psychiatry

nhorikawa@wa3.so-net.ne.jp049-238-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026